Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients

Recruiting now

Conditions studied: Pneumocystis, Immunocompromised Patients

In brief

Evaluate new diagnostic methods using qPCR on non-invasive samples, compared with reference techniques for the positive diagnosis of pneumocystis (PcP) in immunocompromised patients

Key facts

Study ID

NCT06890078

Run by

Assistance Publique - Hôpitaux de Paris

People needed

240

Starts

2025-07-08

Expected to finish

2027-07-08

Last updated by the study team

2026-04-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• adult patients with suspected pneumocystis
• with an indication for bronchial fibroscopy for BAL or induced sputum
• no opposition to the research from the adult patient or his or her next of kin research for patients unable to express their non-opposition

You may not qualify if…

• Pneumocystis treated for more than 72 hours
• pregnancy/breast-feeding
• adult patients deprived of liberty, protected

Where it is running

• Hôpital Lariboisière AP-HP Maladies infectieuses — Paris, France (enrolling)
• Hôpital Saint Louis AP-HP Maladies infectieuses — Paris, France (enrolling)
• Hôpital Saint Louis AP-HP Réanimation — Paris, France (enrolling)
• Hôpital Saint-Louis AP-HP Pneumologie — Paris, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.